Global Adult Vaccines Market Report 2026: Emerging Trends and Growth Scenarios

Uncover key drivers, emerging technologies, and competitive movements shaping the adult vaccines market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Adult Vaccines Market between 2026 and 2030?

The adult vaccines market size has seen significant growth over recent years. It is anticipated to expand from $24.21 billion in 2025 to $26.34 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.8%. Historically, this growth can be attributed to several factors including the rising prevalence of infectious diseases, various government immunization initiatives, the continuous development of novel vaccines, an increasing geriatric population, and the expansion of healthcare infrastructure.

The adult vaccines market size is projected to experience robust expansion over the coming years. This market is set to reach $37.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. Key factors driving this growth during the forecast period include advancements in mRNA and recombinant vaccine technologies, increased investment in adult immunization initiatives, the expansion of cold chain logistics, growing awareness regarding vaccine-preventable diseases, and partnerships between pharmaceutical and biotechnology firms. Significant trends anticipated for the forecast period encompass heightened awareness of adult vaccination, broadening immunization programs, the creation of combination vaccines, an increase in vaccines for chronic disease management, and a growing need for travel and occupational vaccines.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

Which Drivers Are Expected To Impact The Adult Vaccines Market During The Forecast Period?

Higher spending on healthcare fostered the expansion of the adult vaccine market. This expenditure represents the cumulative financial outlay for health services offered to a populace. Elevated healthcare spending frequently directs more capital towards medical research and development. Through dedicated investment in immunization initiatives and broadening vaccine accessibility, health systems can alleviate the impact of avoidable illnesses and enhance public well-being. Furthermore, vaccinating adults offers substantial financial benefits by decreasing the use of healthcare services and minimizing the requirement for costly medical interventions. An illustrative example comes from November 2023, when the Canadian Institute for Health Information, a Canada-based health company, projected Canada’s total health expenditure for 2023 to hit $344 billion, marking an increase of over $9 billion from the 2022 figures. Consequently, the rise in healthcare spending had a favorable effect on the development of the adult vaccine market.

Which Segments Are Driving Activity In The Adult Vaccines Market?

The adult vaccines market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines

3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis

4) By End Users: Healthcare Firms, Hospitals

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines

Which Trends Are Shaping Activity Within The Adult Vaccines Market?

Key companies within the adult vaccines market are focused on advancing technology, such as mRNA-based vaccines, to achieve rapid and precise immune response generation, thereby addressing the growing need for adult immunization against respiratory diseases. An mRNA vaccine functions by using messenger RNA enclosed in lipid nanoparticles to direct human cells to produce specific viral proteins, which in turn elicits an immune response without the use of live or attenuated viruses. As an illustration, in May 2024, Moderna, a US-based biotechnology company, obtained FDA approval for mRESVI, an mRNA respiratory syncytial virus (RSV) vaccine designed for adults aged 60 years and older. This vaccine encodes the RSV prefusion F glycoprotein and is delivered in single-dose, pre-filled syringes, which promotes neutralizing antibody production, enhances safety and efficacy compared to traditional inactivated or live-attenuated vaccines, and expands the available adult immunization options.

Which Major Firms Are Strengthening Their Position In The Adult Vaccines Market?

Major companies operating in the adult vaccines market are GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Which Region Shows The Strongest Potential For Future Expansion In The Adult Vaccines Market?

North America was the largest region in the adult vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Adult Vaccines Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9038&type=smp

Browse Through More Reports Similar to the Global Adult Vaccines Market 2026, By The Business Research Company

Adult Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Pediatric Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795